Calithera Biosciences
Latest round
- Series D
Last raised
- Oct 2013
Total raised
- $81M
Investors
- 7
About Calithera Biosciences
Calithera Biosciences, Inc.Founded in 2010 and headquartered in San Francisco, US, Calithera Biosciences, Inc. specializes in developing cancer therapies.00 mn by selling 8 million shares at a price of USD 10 per share. CEO Susan Molineaux has been pivotal in leading the firm since its inception, steering it towards a focused approach in oncology.Calithera Biosciences, Inc. develops targeted therapies aimed at treating cancer, focusing on small molecule drugs that inhibit metabolic pathways in tumors.In the most recent fiscal year of 2021, Calithera Biosciences, Inc.75 mn.Calithera Biosciences, Inc. aims to expand its oncology product pipeline with new therapies targeting additional cancer types in the coming years.00 mn to accelerate research and development efforts and facilitate entry into emerging markets in Asia and Europe by 2025. Recent strategic moves indicate a focus on enhancing partnerships with other pharmaceutical companies to broaden its product offerings and increase market penetration.
Who invested in Calithera Biosciences
7 investors across 4 rounds
See all investors in Calithera Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Calithera Biosciences
Who invested in Calithera Biosciences?
Calithera Biosciences has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Calithera Biosciences raised?
Calithera Biosciences has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Calithera Biosciences last raise money?
Calithera Biosciences's most recent round on record is a Series D, in Oct 2013.
What does Calithera Biosciences do?
Calithera Biosciences is a pharmaceuticals company.
Where is Calithera Biosciences headquartered?
Calithera Biosciences is headquartered in San Francisco, US.
Which VCs invest in companies like Calithera Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Calithera Biosciences's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Calithera Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.